ArticleThe science of diabetes self-management and care2025
Factors Impacting Pneumococcal Vaccination Among Non-Hispanic Black Adults With Type 2 Diabetes: A Nationwide Cross-Sectional Study.
Article in The science of diabetes self-management and care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PurposeThe purpose of the study was to evaluate factors associated with pneumococcal vaccination among non-Hispanic Black adults with type 2 diabetes mellitus (T2DM).MethodsA cross-sectional, online survey was conducted in December 2023 using a Qualtrics research panel. Eligible participants were adults 19 years and older and non-Hispanic Blacks who self-reported a T2DM diagnosis. The survey comprised 55 items across 5 sections based on the health belief model. Descriptive and bivariate analyses and hierarchical binary logistic regression were used for data analysis.ResultsThere were 330 eligible participants. Two-thirds received at least 1 dose of the pneumococcal vaccine. Participants had a mean age of 51.4 ± 16.8 years; 63.9% were women. Higher perceived susceptibility and higher cues to action were significantly associated with pneumococcal vaccination. However, higher perceived susceptibility, higher severity, geographical location, and history of influenza vaccination emerged as significant predictors, and improved model predictive ability for pneumococcal vaccination was observed (Akaike information criterion = 384.1 vs 423.5) after controlling for sociodemographic and other factors (education level, income, geographical location, diabetes-related complications, treatment types, frequency of health visits, influenza vaccination history, pneumococcal disease history, general vaccine beliefs, perceived mistrust).ConclusionClinical, public health, and health policy programs should address these factors in planning educational campaigns and strategies to increase pneumococcal vaccination among non-Hispanic Black individuals with T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.